miR-503 Is Involved in the Protective Effect of Phase II Enzyme Inducer (CPDT) in Diabetic Cardiomyopathy via Nrf2/ARE Signaling Pathway

Diabetic cardiomyopathy (DCM) is a common heart disease. The Phase II enzyme inducer (CPDT) is a complex enzyme that promotes the expression of antioxidant enzymes through activating nuclear factor erythroid 2-related factor 2 (Nrf2); these compounds have been shown to protect against oxidative stre...

Descripción completa

Detalles Bibliográficos
Autores principales: Miao, Ying, Wan, Qin, Liu, Xiaoyu, Wang, Yu, Luo, Yi, Liu, Dan, Lin, Nengbo, Zhou, Honggang, Zhong, Jiyuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748299/
https://www.ncbi.nlm.nih.gov/pubmed/29404371
http://dx.doi.org/10.1155/2017/9167450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5748299/
https://www.ncbi.nlm.nih.gov/pubmed/29404371
http://dx.doi.org/10.1155/2017/9167450

Ejemplares similares